National Breast and Ovarian Cancer Centre breasthealth  Clinical Best Practice Ovarian Cancer
Clinical Best Practice
Australia's leading breast cancer resource for health professionals 

Site Map  |  Contact Us

What's new  | 
 Clinical Update June 2009 *Special Edition

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

Commentary by Associate Professor Kelly-Anne Phillips

*This issue of Clinical Update is a special joint issue between Clinical Update – Breast Cancer and Clinical Update – Ovarian Cancer.

 

What's new  | 
 RACS Audit

National Breast and Ovarian Cancer Centre and Royal Australasian College of Surgeons National Breast Cancer Audit
Public Health Monitoring Series 2007 Data (Published March 2009)

A total of 4,979 Australian women with early invasive breast cancer were treated by breast surgeons participating in the National Breast Cancer Audit (NBCA) in 2007, the majority of whom were full members of the Breast Section of the Royal Australasian College of Surgeons. Details of these cancers and of their management are described in this report by age at diagnosis, treatment centre location, and referral source. In situ lesions, and invasive cancers recorded by the NBCA among New Zealand women, are not addressed.
pdf View report (pdf 410 kb)

 


 

 

News and events

March 2009

National Breast Cancer Audit Public Health Monitoring Series 2007 Data (Published March 2009)

National Breast and Ovarian Cancer Centre and Royal Australasian College of Surgeons National Breast Cancer Audit now available... more »

Better care, better communication

 

Communication Skills Training website

National Breast Cancer Centre* has launched a new website dedicated to supporting and promoting communication skills training for all cancer health professionals. The Communication skills training section aims to support health professionals to implement evidence-based communication skills training at a local level. It also promotes communication skills as a compulsory professional competence for all health professionals.

 
Research Reports

› 

Aromatase inhibitors as adjuvant therapy for post-menopausal women with hormone receptor-positive early breast cancer:
Supporting evidence for the national breast cancer centre hormonal therapies guidelines working group.

pdf icon › View Report (pdf 442 kb )

› 

Trastuzumab for Her2-positive breast cancer: a systematic review
A systematic review of the best available evidence on the use of trastuzumab (Herceptin®) in breast cancer.

pdf icon › View Report (pdf 540 kb )

  ›  

National Directory of Hospital Based Services

New NBOCC Resources

› 

Information for GPs released about Herceptin®
The National Breast Cancer Centre* has released information for general practitioners about the breast cancer drug Herceptin® (trastuzumab). This information is based on the recently released clinical practice guidelines for the use of Herceptin.

PDF › View guideline (pdf 677 kb)

› 

 

See multidisciplinary care resources

more NBOCC resources

Privacy  |  Disclaimer

© National Breast and Ovarian Cancer Centre 2008

National Breast and Ovarian Cancer Centre | breasthealth | Clinical Best Practice | Ovarian Cancer